Estimate The Effect Of Repeat-Dose Rifampin On The Pharmacokinetics Of CP-690,550 In Healthy Volunteers
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The current study is designed to estimate the effect of rifampin (600 mg orally every 24
hours for 7 days) on pharmacokinetics of single 30 mg dose (CP-690,550) in normal healthy
volunteers